466 results on '"DELLA TORRE, Emanuel"'
Search Results
2. Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework
3. Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial
4. Fibrotic phenotype of IgG4-related disease
5. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
6. Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center
7. IgG4-Related Disease
8. Association of IgG4-related disease and systemic rheumatic disorders
9. Development of an algorithm for IgG4-related disease management
10. IgG4-Related Disease Overview: Pathology, Clinical Picture, and Treatment
11. Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease
12. Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis
13. Advances in the diagnosis and management of IgG4 related disease
14. Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
15. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis
16. Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease
17. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
18. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
19. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
20. Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study
21. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease
22. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement
23. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
24. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
25. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
26. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
27. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
28. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease
29. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
30. Lifetime Allergy Symptoms in IgG4‐Related Disease: A Case–Control Study
31. Lymphadenopathy in the rheumatology practice: a pragmatic approach.
32. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease
33. Lymphadenopathy in the rheumatology practice: a pragmatic approach
34. Interleukin-6 inhibition for the treatment of IgG4 related vasculitis
35. Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes
36. The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral centre
37. B-cell depletion with obinutuzumab for the treatment of IgG4-related disease
38. Plasmablasts: A Promising Biomarker in IgG4-Related Disease
39. IgG4-Related Disease
40. Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease
41. High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
42. Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation.
43. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel
44. Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases
45. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
46. IgG4-related autoimmune liver disease
47. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease
48. Diagnostic value of IgG4 Indices in IgG4-Related Hypertrophic Pachymeningitis
49. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse
50. “How I manage” IgG4-Related Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.